| | | |

Mesothelioma Clinical Trials: Eligibility May Be Too Strict, Study Finds

ByAlex Strauss

mesothelioma clinical trialsA new Australian study suggests that too many people are being left out of mesothelioma clinical trials under current trial rules. 

The researchers say that eligibility requirements around pleural mesothelioma studies are too strict. The result is that many people never have the opportunity to take advantage of investigational treatments only available through studies. 

In addition, the trial data gathered may not really apply to average mesothelioma patients. The Australian researchers are calling for changes that will let more people qualify for mesothelioma clinical trials. 

What Are Mesothelioma Clinical Trials?

Pleural mesothelioma is an intractable cancer of the lining around the lungs. People who get it usually worked in an industry that exposed them to asbestos. Once asbestos gets in the lungs, it stays there indefinitely. Exposed people can get sick 10 to 50 years later. 

There is no cure for mesothelioma. There are not even many good treatments. Mesothelioma clinical trials are the best hope for many patients. Human trials are the next step after laboratory and animal studies of new drugs or treatments. If preclinical data shows a treatment is safe and has promise, a clinical trial will test it in people. 

Studies consistently show that patients who participate in mesothelioma clinical trials live longer than those who have conventional therapies. Unfortunately, only a small percentage of mesothelioma patients take part in potentially life-saving studies. 

The Difficulty of Qualifying for Human Studies

The new Australian study focused on studies of two promising mesothelioma treatments. The trials involved bevacizumab (Avastin) or pembrolizumab (Keytruda). Avastin works by depriving mesothelioma tumors of a blood supply. Keytruda works by blocking mesothelioma cells’ ability to hide from the immune system. 

The large international Avastin trial for people with unresectable pleural mesothelioma went by the acronym MAPS. KEYNOTE-028 was a study of Keytruda for the same population. 

The Australian team evaluated 133 consecutive patients with unresectable pleural mesothelioma on their eligibility for either of these mesothelioma clinical trials. 

Half of the patients did not qualify for the MAPS trial. Thirty-seven percent of the patients did not qualify for the KEYNOTE-028 trial. The most common reasons were being 75 or older, not being able to perform everyday tasks, being on other medications, or having other health conditions. 

The patients who did quality for one of the mesothelioma clinical trials had an overall survival of 32.4 months. Overall survival for the rest of the patients was 20.5 months. 

The researchers say this highlights the need to get more regular patients into studies. They say allowing only the younger and healthier patients into mesothelioma clinical trials can skew the results. 

“Only ≤63% of our patients were eligible for these trials, highlighting the differences between real-world patients and the highly select trial population.,” writes lead author Brandon Lau of Chris O’Brien Lifehouse in the journal Clinical Lung Cancer. “Our patients who participated in clinical trials had superior OS, further emphasizing the selection bias in the trial population.”

For more information about clinical trials, CLICK HERE to visit the US government’s clinical trial database. 

Source:

Lau, B, et al, “Clinical Trials Eligibility of Patients With Malignant Pleural Mesothelioma: Use of Novel Therapies and Outcomes”, March 6, 2020, Clinical Lung Cancer, https://www.clinical-lung-cancer.com/article/S1525-7304(20)30007-3/pdf#%20

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    ByAlex Strauss

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    ByAlex Strauss

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    ByAlex Strauss

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    ByAlex Strauss

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…